Shopping Cart
- Remove All
Your shopping cart is currently empty
Thalidomide-PEG2-C2-NH2 TFA
😃Good
Catalog No. T18812Cas No. 2097509-36-7
Alias Thalidomide-NH-PEG2-C2-NH2 TFA
Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker for use in PROTAC technology[1].
Thalidomide-PEG2-C2-NH2 TFA
😃Good
Catalog No. T18812Alias Thalidomide-NH-PEG2-C2-NH2 TFACas No. 2097509-36-7
Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker for use in PROTAC technology[1].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $82 | 5 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker for use in PROTAC technology[1]. |
| In vitro | PROTACs consist of two ligands joined by a linker; one binds an E3 ubiquitin ligase, and the other targets specific proteins. These compounds leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
| Alias | Thalidomide-NH-PEG2-C2-NH2 TFA |
| Molecular Weight | 518.44 |
| Formula | C21H25F3N4O8 |
| Cas No. | 2097509-36-7 |
| Relative Density. | no data available |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Thalidomide-PEG2-C2-NH2 TFA | purchase Thalidomide-PEG2-C2-NH2 TFA | Thalidomide-PEG2-C2-NH2 TFA cost | order Thalidomide-PEG2-C2-NH2 TFA | Thalidomide-PEG2-C2-NH2 TFA chemical structure | Thalidomide-PEG2-C2-NH2 TFA in vitro | Thalidomide-PEG2-C2-NH2 TFA formula | Thalidomide-PEG2-C2-NH2 TFA molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.